Home / News
Mission updates
Track strategic developments and technical progress from across the Axplora network. These include corporate announcements, expert insights, expansion news and industry updates.
Press Release
September 29, 2026
Axplora launching “Axotecan” to strengthen Global ADC supply
Independent European source of exatecan will expand choice and strengthen supply resilience for ADC developers Gram-scale material available, with validation batches targeted by the end of 2026 and GMP supply planned for late 2027 Cross-business collaboration combines Farmabios’ HPAPI expertise with Novasep CDMO’s integrated ADC capabilities September 29th, 2026 – Axplora, a global manufacturing […]
Article
June 11, 2025
Axplora Strategy Teardown: A Podcast
In a recent episode of the PharmaSource podcast, Arul Ramadurai, Chief Commercial Officer at Axplora, discusses the company’s strategic focus on high-growth therapeutic areas and its customer-driven investment philosophy. Strategic Focus on High-Growth Therapeutic Areas Axplora has positioned itself in two of the fastest-growing therapeutic areas: GLP-1 peptides and antibody-drug conjugates (ADCs). The company recently […]
Article
February 09, 2025
The Road Ahead for Small Molecule APIs in 2025
What does 2025 have in store for the Future of small molecule API development and manufacturing? The landscape for small molecule active pharmaceutical ingredients (APIs) is evolving at speed. Here, Martin Meeson, CEO of Axplora, a leading manufacturer of APIs, talks about the trends that will shape the future of drug development, manufacturing, and supply […]
Partner with us today
Clear your path to launch. Contact our technical experts to manage project complexities and secure your route to market.